Ladenburg Thalmann Upgrades Forte Biosciences Inc. (FBRX) to Buy Apr 8, 2024 06:34AM
Forte Biosciences Inc. (FBRX) PT Raised to $90 at Ladenburg Thalmann, Following Earnings Mar 24, 2021 01:12PM
Forte Biosciences Announces Closing of $46.0 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Nov 2, 2020 04:05PM
Forte Biosciences (FBRX) Announces Pricing of $40 Million Public Offering of Common Stock at $28.50/sh Oct 29, 2020 08:22AM
Forte Biosciences Announces Pricing of $40.0 Million Public Offering of Common Stock Oct 29, 2020 08:00AM


Oct 28, 2020 04:09PM Forte Biosciences (FBRX) Announces Proposed Public Offering of Common Stock
Oct 28, 2020 04:09PM Forte Biosciences Announces Proposed Public Offering of Common Stock
Jun 15, 2020 04:15PM Forte Biosciences, Inc. Announces Closing of Merger With Tocagen